Six months of chemotherapy in low-risk stage 3 colorectal cancer patients increases neuropathy compared to three months. IDEA collaboration found similar survival outcomes between three and six months ...

Topical treatments may help ease chemotherapy-induced peripheral neuropathy, but more research is needed. Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients ...

Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves—those found outside of the brain and spinal cord—are damaged, it can cause pain and ...

Savannah Morning News Content Coach Amy Paige Condon shares the story of her mother's final meal on Thanksgiving 2014 and the ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect to chemotherapy treatment. It can cause symptoms that range from sensitivity to touch and numbness to neuropathic pain in ...

Gorgas, President and CEO of Artelo Biosciences. “Starting with ART26.12, our promising Fatty Acid Binding Protein 5 (FABP5) inhibitor drug candidate, we received FDA clearance to begin trials in ...

vitamin deficiencies and cancer treatments like chemotherapy. The most common type of peripheral neuropathy is caused by diabetes. Diabetic neuropathy occurs when high blood sugar levels damage ...

The company also hopes to make the device usable at home. In parallel, Luminate is developing another device to treat chemotherapy-induced neuropathy. This new development could help alleviate the ...

ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...